Cardinal Capital Management Organon & Co. Transaction History

Cardinal Capital Management

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Jul 12, 2024	BUY	$16.59 - $23.77 $9,373 - $13,430	565 Added 4.68%	12,636 $219,000
Q3 2023 Oct 16, 2023	BUY	$16.59 - $23.77 $9,373 - $13,430	565 Added 4.68%	12,636 $219,000
Q2 2023 Jul 12, 2024	BUY	$19.27 - $24.63 $232,608 - $297,308	12,071 New	12,071 $251,000
Q2 2023 Jul 12, 2023	BUY	$19.27 - $24.63 $7,226 - $9,236	375 Added 3.21%	12,071 $251,000
Q1 2023 Apr 18, 2023	BUY	$21.42 - $32.08 $23,069 - $34,550	1,077 Added 10.14%	11,696 $275,000
Q4 2022 Jan 20, 2023	BUY	$23.31 - $28.61 $6,596 - $8,096	283 Added 2.74%	10,619 $0
Q3 2022 Oct 21, 2022	BUY	$23.4 - $34.25 $22,276 - $32,606	952 Added 10.14%	10,336 $242,000
Q2 2022 Aug 04, 2022	BUY	$31.66 - $38.9 $22,826 - $28,046	721 Added 8.32%	9,384 $317,000
Q1 2022 Apr 21, 2022	BUY	$30.45 - $39.36 $42,964 - $55,536	1,411 Added 19.46%	8,663 $303,000
Q4 2021 Jan 18, 2022	BUY	$28.67 - $37.13 $6,278 - $8,131	219 Added 3.11%	7,252 $221,000
Q3 2021 Oct 21, 2021	BUY	$28.63 - $35.64 $8,445 - $10,513	295 Added 4.38%	7,033 $231,000
Q2 2021 Jul 14, 2021	BUY	$28.45 - $38.0 $191,696 - $256,044	6,738 New	6,738 $204,000

791

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Cardinal Capital Management, based on Form 13F filings with the SEC.

Stay updated on Cardinal Capital Management with notifications on news.